Pyrazolo[3,4-d]pyrimidines as potent antiproliferative and proapoptotic agents toward A431 and 8701-BC cells in culture via inhibition of c-Src phosphorylation

Journal of Medicinal Chemistry
Fabio CarraroMaurizio Botta

Abstract

We report here the synthesis of new pyrazolo[3,4-d]pyrimidine derivatives along with their biological properties as inhibitors of isolated Src and cell line proliferation (A431 and 8701-BC cells). Such compounds block the growth of cancer cells by interfering with the phosphorylation of Src, and they act as proapoptotic agents through the inhibition of the anti apoptotic gene BCL2. Several of them were found to be more active than the reference compound (1-(tert-butyl)-3-(4-chlorophenyl)-4-aminopyrazolo[3,4-d]pyrimidine, PP2) in inhibiting cell proliferation and in inducing apoptosis, and as active as PP2 in the inhibition of the phosphorylation of isolated Src. Moreover, molecular modeling simulations have been performed to hypothesize the way, at the molecular level, by which the inhibitors were able to act as antiproliferative agents.

References

Jan 1, 1992·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·N N MazurenkoF L Kisseljov
Apr 20, 1990·Cell·A Ullrich, J Schlessinger
Aug 1, 1989·British Journal of Cancer·S MinafraD E Woolley
Nov 1, 1973·Journal of the National Cancer Institute·D J GiardW P Parks
Jan 1, 1995·Annual Review of Immunology·S Cory
Jan 1, 1994·Annual Review of Cell Biology·P van der GeerR A Lindberg
Apr 1, 1994·Trends in Biochemical Sciences·G de Murcia, J Ménissier de Murcia
Feb 1, 1996·Genes to Cells : Devoted to Molecular & Cellular Mechanisms·K Neet, T Hunter
Jan 20, 1998·Trends in Biochemical Sciences·M E NobleL N Johnson
Jan 1, 1997·Annual Review of Cell and Developmental Biology·S M Thomas, J S Brugge
Sep 15, 1998·Biochemical and Biophysical Research Communications·L G Sheffield
Jan 7, 2000·Experimental Cell Research·C L Abram, S A Courtneidge
Dec 15, 2000·Oncogene·J D BjorgeD J Fujita
Jun 5, 2001·Nature Reviews. Molecular Cell Biology·G S Martin
May 8, 2002·Nature Reviews. Molecular Cell Biology·Margaret C FrameJohn A Wyke
Oct 18, 2002·Journal of Medicinal Chemistry·Francesco BondavalliMaria Letizia Trincavellic
Dec 21, 2002·Differentiation; Research in Biological Diversity·Isaiah J Fidler
Mar 19, 2004·Journal of Medicinal Chemistry·Fabio CarraroMaurizio Botta
Mar 24, 2004·Biochemistry·Alessandra ConaMaurizio Botta
Apr 14, 2004·Current Pharmaceutical Design·T J StoutD J Matthews
Mar 5, 2005·Bioorganic & Medicinal Chemistry Letters·Ana Carolina Barrios SosaJennifer M Golas

❮ Previous
Next ❯

Citations

Apr 1, 2010·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Alessandra RossiAntonio Giordano
Jul 17, 2012·Acta Crystallographica. Section E, Structure Reports Online·Mohammed Iqbal A KhaziI M Khazi
Apr 26, 2012·Future Medicinal Chemistry·Francesca MusumeciMaurizio Botta
Mar 22, 2014·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Khaled R A AbdellatifRania B Bakr
Dec 19, 2015·Journal of Enzyme Inhibition and Medicinal Chemistry·Ahmed MalkiXiaozhuo Chen
Jan 1, 2009·Expert Opinion on Drug Discovery·Moorthy Ss PalankiGlenn Noronha
Jun 19, 2010·Expert Opinion on Investigational Drugs·Silvia SchenoneMaurizio Botta
Aug 29, 2009·Medicinal Research Reviews·S SchenoneM Botta
Oct 25, 2016·Future Medicinal Chemistry·Pedro Alves Bezerra MoraisHeberth de Paula
Jan 4, 2008·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Adriano SpreaficoAnnalisa Santucci
Jun 4, 2020·International Journal of Molecular Sciences·Filippo TorrisiSamuel Valable
Nov 26, 2019·European Journal of Medicinal Chemistry·Feng-Tao LiuZhi-Hao Shi
Jun 6, 2014·ACS Medicinal Chemistry Letters·Giulia VignaroliMaurizio Botta
Jan 30, 2013·Inorganic Chemistry·Alicia Domínguez-MartínJuan Niclós-Gutiérrez
Apr 8, 2014·The Journal of Organic Chemistry·Yang XiongSong Cao
Sep 18, 2021·Chemistry : a European Journal·Solène MorandSamuel Couve-Bonnaire

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

BCL-2 Family Proteins

BLC-2 family proteins are a group that share the same homologous BH domain. They play many different roles including pro-survival signals, mitochondria-mediated apoptosis and removal or damaged cells. They are often regulated by phosphorylation, affecting their catalytic activity. Here is the latest research on BCL-2 family proteins.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Cell Checkpoints & Regulators

Cell cycle checkpoints are a series of complex checkpoint mechanisms that detect DNA abnormalities and ensure that DNA replication and repair are complete before cell division. They are primarily regulated by cyclins, cyclin-dependent kinases, and the anaphase-promoting complex/cyclosome. Here is the latest research.